Fig. 2From: Epilepsy control with carbamazepine monotherapy from a genetic perspectiveCarbamazepine plasma levels between the responsive and non-responsive groups at 3-month and 6-month. (a). 3rd month of the therapy. (b). 6th month of the therapy. Unpaired student t test was used to compare the plasma level of carbamazepine among responder and non-responder people with epilepsyBack to article page